Presented is an ultra-simple wearable local sweat volume monitoring patch based on swellable hydrogels.

No abstract

No abstract

The work focused on manufacturing improved drug loaded multifunctional magnetic nanoparticles that can overcome the relative non-specificity and potential side-effects of some chemotherapeutic drugs to healthy tissues. A new drug delivery system, Chelerythrine (CHE) and Fe3O4 loaded multi-walled carbon nanotubes (Fe3O4/MWNTs-CHE nanocomposites) that can target hepatocytes when treating malignant tumors, was prepared through a simple adsorption method. The formulation and structure of the Fe3O4/MWNTs-CHE nanocomposites were characterized by vibrating sample magnetometer (VSM), Fourier Transform infrared spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). The cytotoxicity and anti-proliferation effect from the prepared nanocomposites were in vitro tested on human hepatocarcinoma HepG2 and normal liver LO2 cell lines. The results showed the saturated magnetization of Fe3O4/MWNTs-CHE nanocomposites could reach to 45.4O3 emu/g, and the in vitro CHE release behavior exhibited a biphasic release pattern. Moreover, the in vitro cytotoxicity studies revealed that the Fe3O4/MWNTs-CHE nanocomposites showed an efficient inhibition rate to HepG2 cell line and exhibited a lower cytotoxicity to LO2 cell line in comparison to the native CHE. Therefore, the multifunctional Fe3O4/MWNTs-CHE nanocomposites should be a useful and promising candidate for treatment of malignant tumors.

No abstract

The detection of hepatitis B surface antigen (HBsAg), a coat protein secreted by hepatitis B virus, is a common method for confirming infection in early diagnosis. A new composite of graphene oxide‐ferrocene‐chitosan (GO‐Fc‐CS) was synthesized and used to develop an electrochemical immunosensor with a GO‐Fc‐CS/Au‐nanoparticle layer film for HBsAg detection. The modified layer film exhibited not only enhanced electron conductivity, but also strong reversible redox signal for current changes, excellent biocompatibility, and good film‐forming ability for binding a large number of antibodies. The immunosensor exhibits a wide linear range from 0.05 to 150 ng/mL and detection limit of 0.01 ng/mL for HBsAg. The excellent performance in HBsAg detection suggests that the proposed immunosensor has potential application in clinical diagnosis.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

No abstract